Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1701–1750 of 18616
On April 28, 2025, Spero Therapeutics, Inc. (the “Company”) announced that effective as of May 2, 2025 (the “Effective Date”), Esther Rajavelu will serve as the Company’s President and Chief Executive Officer.
the Board appointed Ashley McEvoy as President and Chief Executive Officer of the Company and as a member of the Board as a Class III Director.
James R. Hollingshead, who has agreed with the Board that his employment will cease effective as of April 28, 2025, and resigned from the Board.
Mr. Kurt Sievers, the CEO and President of NXP Semiconductors N.V. (the “Company”), provided notice that he would voluntarily retire as CEO and executive director of the Company on October 28, 2025.
designated Mr. Sotomayor as CEO and temporary executive director of the Company effective as of October 28, 2025
On April 28, 2025, MongoDB, Inc. (the “Company”) announced the appointment of Michael J. Berry as the Company’s Chief Financial Officer effective May 27, 2025.
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
On April 18, 2025, Michael C. Greiner announced that he will leave the Company to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
The Company has appointed Jason M. Pickett as Interim Chief Financial Officer and Treasurer, effective April 14, 2025.
Effective upon Mr. Santoro’s appointment, Ms. Mary Doyle has resigned as the Company’s principal financial officer and principal accounting officer and her consulting agreement with the Manager has terminated.
The Board of Directors of Rithm Property Trust Inc. (the “Company”) approved the appointment of Nicola Santoro, Jr. as the Company’s Chief Financial Officer and Chief Accounting Officer, effective as of April 28, 2025.
On April 22, 2025, BOXABL Inc. (the “Company”) appointed Galiano Tiramani as Co-Chief Executive Officer
Mr. Bong Dennis has been appointed as President, Chief Executive Officer, and Chief Financial Officer of the Company as at April 22, 2025.
Michael Stubblefield and Avantor, Inc. (the “Company”) agreed to initiate a leadership transition and Mr. Stubblefield agreed to step down from his role as Director, President and Chief Executive Officer of the Company, effective upon the appointment of his successor.
On April 22, 2025, Michael Lee (age 52) was appointed Chief Financial Officer of Arhaus, Inc. (the “Company”), effective May 12, 2025.
Stephen M. Shafer, the Company’s President and Chief Operating Officer, has been elected Chief Executive Officer of the Company effective July 1, 2025, in addition to serving in his capacity as President.
On April 24, 2025, the Board of Directors (the “Board”) of Spire Inc. (the “Company”) appointed Scott Doyle, currently the Chief Operating Officer of the Company and Chief Executive Officer of Spire Missouri Inc. and Spire Alabama Inc., as President and Chief Executive Officer (“CEO”) of the Company effective April 24, 2025 (the “Transition Effective Date”).
Mr. Doyle will replace Steve Lindsey, whose employment as President and CEO of the Company was terminated without “Cause” (as defined under the Company’s Executive Severance Plan) and who resigned as a member of the Board, in each case, effective as of the Transition Effective Date.
In the interim, Thomas E. Sullivan has been appointed to serve as the Company’s Interim Chief Financial Officer, effective upon Mr. Murphy’s departure.
On April 21, 2025, Timothy J. Murphy notified Repay Holdings Corporation (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective May 15, 2025.
As previously announced, on February 13, 2025 the Board appointed John D. Calys, the Company’s Senior Vice President, Global Controller and Chief Accounting Officer, to succeed its current Chief Financial Officer, George Kilguss, upon his retirement on May 31, 2025.
As previously announced, on February 13, 2025 the Board appointed John D. Calys, the Company’s Senior Vice President, Global Controller and Chief Accounting Officer, to succeed its current Chief Financial Officer, George Kilguss, upon his retirement on May 31, 2025.
Nathan Bennett, who served as the Company's Chief Accounting Officer/Interim Chief Financial Officer from January 1, 2024 to April 21, 2025, was appointed as Chief Financial Officer of the Company effective April 21, 2025.
On April 22, 2025, Michael J. Rugen resigned as the Chief Financial Officer of New Era Helium, Inc. (the “ Company ”) with an effective date of May 31, 2025 (the “ Effective Date ”).
In connection with the Merger, as of the Effective Time, Shai Terem resigned from his role as Chief Executive Officer and President of the Company
On April 24, 2025, Assaf Zipori informed the Board of Directors of the Company (the “Board”) that he would resign from his position as Chief Financial Officer, Treasurer and Secretary of the Company, effective immediately
On April 21, 2025, the Company announced the appointment of Kurt Keller as the chief financial officer (CFO) of the Company.
On April 22, 2025, Mr. Bernard Birkett notified West Pharmaceutical Services, Inc. (the “Company”) of his intention to retire as Senior Vice President & Chief Financial Officer later this year.
announced the appointment of David A. Pace to the position of President and Chief Executive Officer (“President and CEO”) of the Company, effective April 24, 2025
Mr. Pace replaces G.J. Hart as the Company’s President and CEO, who will also depart from the Board of Directors (the “Board”) of the Company as of the Effective Date.
Further, on April 24, 2025, the Partnership announced the expansion of responsibilities for Andrew Miedler, the Partnership’s Chief Financial Officer. Effective as of June 1, 2025, Mr. Miedler will assume responsibility for digital and data and will continue in his role as the Partnership’s principal financial officer.
Mr. Dziedzic will retire as President and CEO and step down from the Board, effective October 24, 2025.
the Board also appointed Payman Khales, the Company’s current Chief Operating Officer, to succeed Mr. Dziedzic as President and CEO
On April 23, 2025, the Company’s Board of Directors elected Howard Jonas, the Company’s Executive Chairman and Chairman of the Board, as the Company’s Chief Executive Officer and President, effective June 1, 2025.
On April 23, 2025, William Conkling resigned as Chief Executive Officer and President of Rafael Holdings, Inc. (the “Company”), effective May 31, 2025.
On April 24, 2025, the Board of Directors of Healthpeak Properties, Inc. (the “Company”) appointed Kelvin O. Moses as the Company’s Chief Financial Officer and principal financial officer, effective immediately, pursuant to the Company’s succession plan.
Mr. Balu’s decision to resign is not the result of any dispute or disagreement with the Company, the Company’s management or the Company’s Board of Directors on any matter relating to the Company’s operations, policies or practices.
On April 22, 2025, the Board of Directors of Wellgistics Health, Inc. (the “Company”) appointed Mark DiSiena as Chief Financial Officer of the Company, effective as of April 22, 2025
Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025
On April 23, 2025, Boston Scientific Corporation (the “Company”) announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025
On the Effective Date, Mr. Kutsor will succeed Dave Rawden from AlixPartners LLP, a leading global business advisory firm, who has served as the Company’s Interim Chief Financial Officer since November 20, 2024.
On April 23, 2025, Evolv Technologies Holdings, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed George C. Kutsor as the Company’s new Chief Financial Officer on April 21, 2025, to be effective one business day following the filing of the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2024 (the “Effective Date”).
Charles Todd, Jr.. (the “Executive”), who, in conjunction with the execution the Employment Agreement, was appointed as the Company’s Chief Executive Officer
On April 17, 2025, the Company’s board of directors (the “Board”) appointed Ms. Chenyang Wang as the Company’s acting chief financial officer, with effect from April 18, 2025.
On April 18, 2025, Mr. Jing Jin, the chief financial officer of Greenland Technologies Holding Corporation, a business company formed in the British Virgin Islands (the “Company”), resigned as the chief financial officer of the Company, effective April 18, 2025.
On April 17, 2025, John (Fei) Han was appointed as the Chief Financial Officer of the Defi Development Corp., formerly known as Janover Inc. (the “ Company ”).
In connection with Mr. Han’s appointment as the Chief Financial Officer of the Company, Mr. Rosenbloom stepped down as the Chief Financial Officer of the Company, effective immediately.
The reappointment follows Mike Nelson’s departure from the role of Chief Executive Officer
On April 18, 2025 the Board of Directors of Basanite, Inc. (the “Company”) approved the reappointment of Ronald LoRicco, Sr. as the Company’s Acting Interim Chief Executive Officer, effective immediately.
On April 17, 2025, Adagio Medical Holdings, Inc. (the “Company”) appointed Daniel George as the Company’s Interim Chief Financial Officer and designated Mr. George as its principal financial officer and principal accounting officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.